Insulin Degludec Titration Using Mobile Insulin Dosing System
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 240 participants.
Also called NCT03091712
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 240 participants
- Sponsor
- Glooko
- Registry
-
NCT03091712
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03091712. Randomized; no masking; primary purpose treatment. Start 2017-05-05 (actual); primary completion 2019-08-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Insulin Degludec Titration Using Mobile Insulin Dosing System
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Device)
- Glooko Mobile Insulin Dosing System(MIDS)
- Lead sponsor
- Glooko
Record details
- Record id
cardio:ct-nct03091712- Content hash
3c33e637fe4761b5e46d2426cf6284540b48463168428745a437f2acedfcfebc